Your browser doesn't support javascript.
loading
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.
Vranckx, Pascal; Valgimigli, Marco; Eckardt, Lars; Tijssen, Jan; Lewalter, Thorsten; Gargiulo, Giuseppe; Batushkin, Valerii; Campo, Gianluca; Lysak, Zoreslava; Vakaliuk, Igor; Milewski, Krzysztof; Laeis, Petra; Reimitz, Paul-Egbert; Smolnik, Rüdiger; Zierhut, Wolfgang; Goette, Andreas.
Afiliação
  • Vranckx P; Department of Cardiology and Intensive Care, Jessa Ziekenhuis, Faculty of Medicine and Life Sciences at the Hasselt University, Hasselt, Belgium. Electronic address: pascal.vranckx@jessazh.be.
  • Valgimigli M; Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Eckardt L; Atrial Fibrillation Network, Munster, Germany; Department of Cardiology and Angiology, Division of Electrophysiology, University of Munster, Munster, Germany.
  • Tijssen J; Department of Cardiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands; Cardialysis, Rotterdam, Netherlands.
  • Lewalter T; Atrial Fibrillation Network, Munster, Germany; Department of Cardiology, Hospital Munich South, Munich, Germany; University of Bonn, Bonn, Germany.
  • Gargiulo G; Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy.
  • Batushkin V; Department of Cardiology, Kyiv City Clinical Hospital #5, Kiev, Ukraine.
  • Campo G; Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, Venice, Italy; Maria Cecilia Hospital, GVM Care and Research, Cotignola, Italy.
  • Lysak Z; Department of Cardiac Rehabilitation, Oleksandrivska Kyiv City Clinical Hospital, Kiev, Ukraine.
  • Vakaliuk I; Department Internal Medicine No2 and Nursing, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine; Department of Anesthesiology with Wards of Intensive Care, Ivano-Frankivsk Regional Clinical Cardiological Clinic, Ivano-Frankivsk, Ukraine.
  • Milewski K; Center for Cardiovascular Research and Development, American Heart of Poland Katowice, Poland; The Jerzy Kukuczka Academy of Physical Education, Faculty of Physiotherapy, Katowice, Katowice, Poland.
  • Laeis P; Daiichi Sankyo Europe, Munich, Germany.
  • Reimitz PE; Daiichi Sankyo Europe, Munich, Germany.
  • Smolnik R; Daiichi Sankyo Europe, Munich, Germany.
  • Zierhut W; Daiichi Sankyo Europe, Munich, Germany.
  • Goette A; Atrial Fibrillation Network, Munster, Germany; Cardiology and Intensive Care Medicine, St Vincenz-Hospital, Paderborn, Germany; Working Group of Molecular Electrophysiology, University Hospital Magdeburg, Magdeburg, Germany. Electronic address: andreas.goette@vincenz.de.
Lancet ; 394(10206): 1335-1343, 2019 Oct 12.
Article em En | MEDLINE | ID: mdl-31492505
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Fibrilação Atrial / Tiazóis / Vitamina K / Fibrinolíticos / Intervenção Coronária Percutânea / Inibidores do Fator Xa Tipo de estudo: Clinical_trials / Etiology_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Fibrilação Atrial / Tiazóis / Vitamina K / Fibrinolíticos / Intervenção Coronária Percutânea / Inibidores do Fator Xa Tipo de estudo: Clinical_trials / Etiology_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2019 Tipo de documento: Article